Hospital authorities said they expect phase 3 of the trial to begin by the first week of December. “A total of 148 volunteers have been given the first dose, of which 96 have been given the second dose. Phase 2 of the clinical trial will conclude in the next week,” said Dr Ramesh Bharmal, dean, BYL Nair Hospital. According to sources, KEM Hospital is also in the last stage of the second round of phase 2 of the trial. After phase 1 of the clinical trial, Covishield vaccine was found to induce a strong immune response.

Source: Hindustan Times November 18, 2020 19:14 UTC